Izmir Biyotip Ve Genom Merkezi

Izmir Biyotip Ve Genom Merkezi is an SME in İzmir, Türkiye that has taken part in 10 EU-funded projects since 2018, receiving €5.5M in EU funding and leading 4 as coordinator.

EU funding received€5.5M
EU projects10
As coordinator4
Running now7
First EU project2018
Latest project2026
CountryTürkiye
EU registration (PIC)906758620
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Izmir Biyotip Ve Genom Merkezi's own share of each project, not the project's full budget.

  • Horizon Europe€2.8M · 7 projects
  • Horizon 2020€2.7M · 3 projects

Projects

10 EU-funded projects, newest first. Izmir Biyotip Ve Genom Merkezi led 4 of them as coordinator. Each links to the official record.

  • DiagMDSAssociated partner

    Towards novel approaches for Myelodysplastic Syndromes diagnosis to Strengthen Research Human Capital with Cross-Sectoral and Interdisciplinary Staff mobility

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • STEM-COREPartner

    Stem Cell Therapy Development for Corneal Epithelium Regeneration

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €237ktheir share
  • CLARISURGECoordinator

    Advancing Mountable Endoscopic Cap for Precision Oesophageal Mucosal Resurfacing with Non-Thermal Ablation

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.6Mtheir share
  • ERDERAPartner

    EUROPEAN RARE DISEASES RESEARCH ALLIANCE

    Horizon Europe · 2024–2031 · Project on CORDIS ↗

    €222ktheir share
  • CHIRONCoordinator

    The role of the non-canonical death receptor signalling in cancer and immune cells

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €202ktheir share
  • halt-RONINPartner

    Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €336ktheir share
  • NeoVasculoStopPartner

    NATURAL INTRAOCULAR PHOTOACTIVATION OF COMPOUNDS TO FIGHT RETINOPATHIES

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €186ktheir share
  • RareBoostCoordinator

    Boosting the Rare Disease research and innovation capacity of the Izmir Biomedicine and Genome Center

    Horizon 2020 · 2020–2027 · Project on CORDIS ↗

    €2.5Mtheir share
  • CLEANCoordinator

    Well-Confined Mucosal LasEr Ablation with a Negative Pressure Based Endoscopy Capsule

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €157ktheir share
  • DISCOVERPartner

    Death receptor signalling in tumour immune editing

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €27ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • biomaterials
  • cell biology
  • diabetes
  • drug discovery
  • ecosystems
  • genomes
  • hematology
  • histology
  • immunology
  • inflammatory diseases
  • laser physics
  • machine learning
  • metabolomes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime